Search results
Results from the WOW.Com Content Network
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease , cardiovascular disease , arthritis , diabetes , depression , paediatric and various other medical conditions. [ 3 ]
Emmanuel Katongole (born 27 April 1962), is a Ugandan statistician, economist, businessman, entrepreneur and industrialist. He is the executive chairman of Cipla Quality Chemical Industries Limited (CQCIL), the only company in Sub-Saharan Africa, that is authorized to manufacture triple-combination anti retro-viral drugs.
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...
The company posted an 18.3% rise in consolidated net profit to 11.78 billion rupees ($140.8 million) for the quarter ended June 30, surpassing analysts' estimates of 11.10 billion rupees, as per ...
Quality Chemical Industries Limited (Qcil), formerly Cipla Quality Chemical Industries Limited (CiplaQCIL) is a pharmaceutical manufacturing company, established in Uganda by Ugandans in 2005. The company is committed to advancing wellness and is the largest producer of World Health Organization (WHO) pre-qualified HIV/AIDS and Malaria ...
Signed in Goa, India between Cipla BioTec and the South African government, it will see a manufacturing plant producing biosimilars of affordable medicines for cancer and autoimmune diseases, to be sold in Africa and the world. [9] It will be fully operational in 2018 with between 300 and 480 jobs created. [9]
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Yusuf Khwaja Hamied (born 25 July 1936) is an Indian scientist, billionaire businessman and the chairman of Cipla, a generic pharmaceuticals company founded by his father Khwaja Abdul Hamied in 1935. [1]